Neurofeedback Training Using Near-infrared Spectroscopy to Improve Eating Behavior and Support Weight Loss in Women with Food Addiction and Obesity
Led by Rennes University Hospital · Updated on 2025-08-08
50
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying obesity and food addiction by evaluating a neurofeedback therapy based on near-infrared spectroscopy fNIRS to increase brain activity in the dorsolateral prefrontal cortex dlPFC. This approach aims to improve eating behavior and promote long-term weight loss in obese individuals. The trial is sponsored by Rennes University Hospital and focuses on the connection between brain control areas and food addiction behaviors.
Participants will undergo eight neurofeedback sessions over four weeks, with two sessions per week. The training involves using a visual gauge to help increase dlPFC brain activity. The first and last sessions take place during MRI scans. There is also a control group receiving sham neurofeedback, where participants see random signals unrelated to their brain activity. Each session lasts 15 minutes.
During the study, researchers will assess changes through clinical data, questionnaires, and brain imaging before and after the neurofeedback training, including follow-ups three months later. They will measure brain activity differences, blood pressure, biological tests, mental health status, and eating behavior questionnaires. The trial includes monitoring patients progress and responses to the therapy to evaluate its impact on food addiction and obesity.
CONDITIONS
Brief Title
Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.
Research Team
M
Marie-Laure GERVAIS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Eligible for obesity surgery according to 2009 French High Authority on Health criteria (BMI ≥40 or BMI ≥35 with comorbidities)
Right-handed
Diagnosed with food addiction by YFAS 2.0 questionnaire
Affiliated with a social security system
Provided free and informed written consent
You will not qualify if you...
Psychotic psychiatric disorders such as schizophrenia and bipolar disorder
Use of psychotropic drugs except stable antidepressants for at least 3 weeks and benzodiazepines
Addiction to alcohol or other psychoactive substances except tobacco
History of bariatric surgery
Currently receiving treatment in a nutrition unit
Insufficient command of French language
Pregnant or breastfeeding women
Persons under legal protection or deprived of liberty
Contraindications to MRI
Inability to perform fNIRS due to light blockage or attenuation at capillary level
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 4 weeks
Participants receive neurofeedback training based on near-infrared spectroscopy to increase brain activity in the dlPFC. The protocol includes 8 sessions over 4 weeks, with 2 sessions per week. The first and last sessions occur in an MRI context. Each session lasts 15 minutes.
2 visits per week for 4 weeks (total 8 sessions)
Follow-up
Duration - Up to 4 months
Participants are monitored for changes in brain activity, eating behavior, blood pressure, biological markers, and mental health up to 4 months after completing neurofeedback training.
Visits timed at 1 month and 4 months after treatment completion
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Virtual Nutrition Education to Prevent Weight Gain During Maintenance Chemotherapy in Children and Adolescents with Acute Lymphoblastic Leukemia
Study of Gene Expression in Tissues Related to Blood Sugar and Weight in Adults Undergoing Abdominal Surgery
Phase 1 Study of Single-Dose Semaglutide Nasal Spray to Assess Safety, Tolerability, and Pharmacokinetics in Adults with Overweight or Obesity Aged 18 to 65
Evaluating Multimodal Ultrasound to Monitor Muscle Mass in Metabolic Syndrome, Type 2 Diabetes, and Obesity
Reducing Obesity and Related Health Risks in Native American Employees at Twin Arrows Casino Using a Culturally Relevant Plant-Rich Diet
Study of Safety, Tolerability, and Effects of NNC0721-8060 Compared to Semaglutide and Placebo in Adults with Overweight or Obesity
Phase 12a Study Evaluating Safety and Effects of ARO-ALK7 in Adults With Obesity, With or Without Type 2 Diabetes
Master Protocol Evaluating Multiple Investigational Treatments for Chronic Weight Management in Adults with Obesity or Overweight
Evaluating a Digital Tool to Help Clinicians Prescribe Personalized Exercise for Adults with Cardiovascular Disease Risk Factors in a Randomized Crossover Trial
Testing a Responsive Parenting Program to Prevent Obesity in High-Risk Infants Through Pediatric Primary Care
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Neurofeedback intervention based on functional near-infrared spectroscopy compared with sham control to improve inhibitory cognitive control in patients with severe obesity and food addiction: The protocol of a monocentric prospective randomized parallel-group single-blind interventional study.
Ilona Renaud, Nicolas Coquery, Marie-Océane Guittière...